173 related articles for article (PubMed ID: 19734138)
1. Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study.
Keller C; Katz R; Sarnak MJ; Fried LF; Kestenbaum B; Cushman M; Shlipak MG;
Nephrol Dial Transplant; 2010 Jan; 25(1):119-24. PubMed ID: 19734138
[TBL] [Abstract][Full Text] [Related]
2. Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA).
Keller C; Katz R; Cushman M; Fried LF; Shlipak M
BMC Nephrol; 2008 Aug; 9():9. PubMed ID: 18681974
[TBL] [Abstract][Full Text] [Related]
3. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
4. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.
Gupta J; Mitra N; Kanetsky PA; Devaney J; Wing MR; Reilly M; Shah VO; Balakrishnan VS; Guzman NJ; Girndt M; Periera BG; Feldman HI; Kusek JW; Joffe MM; Raj DS;
Clin J Am Soc Nephrol; 2012 Dec; 7(12):1938-46. PubMed ID: 23024164
[TBL] [Abstract][Full Text] [Related]
5. Association of serum albumin levels with kidney function decline and incident chronic kidney disease in elders.
Lang J; Katz R; Ix JH; Gutierrez OM; Peralta CA; Parikh CR; Satterfield S; Petrovic S; Devarajan P; Bennett M; Fried LF; Cummings SR; Sarnak MJ; Shlipak MG
Nephrol Dial Transplant; 2018 Jun; 33(6):986-992. PubMed ID: 28992097
[TBL] [Abstract][Full Text] [Related]
6. Inflammation, kidney function and albuminuria in the Framingham Offspring cohort.
Upadhyay A; Larson MG; Guo CY; Vasan RS; Lipinska I; O'Donnell CJ; Kathiresan S; Meigs JB; Keaney JF; Rong J; Benjamin EJ; Fox CS
Nephrol Dial Transplant; 2011 Mar; 26(3):920-6. PubMed ID: 20682604
[TBL] [Abstract][Full Text] [Related]
7. Clinical and subclinical cardiovascular disease and kidney function decline in the elderly.
Shlipak MG; Katz R; Kestenbaum B; Fried LF; Siscovick D; Sarnak MJ
Atherosclerosis; 2009 May; 204(1):298-303. PubMed ID: 18848325
[TBL] [Abstract][Full Text] [Related]
8. Residual Associations of Inflammatory Markers with eGFR after Accounting for Measured GFR in a Community-Based Cohort without CKD.
Schei J; Stefansson VT; Mathisen UD; Eriksen BO; Solbu MD; Jenssen TG; Melsom T
Clin J Am Soc Nephrol; 2016 Feb; 11(2):280-6. PubMed ID: 26668020
[TBL] [Abstract][Full Text] [Related]
9. Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study.
Singh D; Whooley MA; Ix JH; Ali S; Shlipak MG
Nephrol Dial Transplant; 2007 Apr; 22(4):1087-92. PubMed ID: 17210589
[TBL] [Abstract][Full Text] [Related]
10. Inflammation and coagulation markers and kidney function decline: the Multi-Ethnic Study of Atherosclerosis (MESA).
Hiramoto JS; Katz R; Peralta CA; Ix JH; Fried L; Cushman M; Siscovick D; Palmas W; Sarnak M; Shlipak MG
Am J Kidney Dis; 2012 Aug; 60(2):225-32. PubMed ID: 22560844
[TBL] [Abstract][Full Text] [Related]
11. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.
Bash LD; Erlinger TP; Coresh J; Marsh-Manzi J; Folsom AR; Astor BC
Am J Kidney Dis; 2009 Apr; 53(4):596-605. PubMed ID: 19110358
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and Progression of CKD: The CRIC Study.
Amdur RL; Feldman HI; Gupta J; Yang W; Kanetsky P; Shlipak M; Rahman M; Lash JP; Townsend RR; Ojo A; Roy-Chaudhury A; Go AS; Joffe M; He J; Balakrishnan VS; Kimmel PL; Kusek JW; Raj DS;
Clin J Am Soc Nephrol; 2016 Sep; 11(9):1546-1556. PubMed ID: 27340285
[TBL] [Abstract][Full Text] [Related]
13. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study.
Keller CR; Odden MC; Fried LF; Newman AB; Angleman S; Green CA; Cummings SR; Harris TB; Shlipak MG
Kidney Int; 2007 Feb; 71(3):239-44. PubMed ID: 17183246
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory and prothrombotic markers and the progression of renal disease in elderly individuals.
Fried L; Solomon C; Shlipak M; Seliger S; Stehman-Breen C; Bleyer AJ; Chaves P; Furberg C; Kuller L; Newman A
J Am Soc Nephrol; 2004 Dec; 15(12):3184-91. PubMed ID: 15579522
[TBL] [Abstract][Full Text] [Related]
15. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency.
Shlipak MG; Fried LF; Crump C; Bleyer AJ; Manolio TA; Tracy RP; Furberg CD; Psaty BM
Circulation; 2003 Jan; 107(1):87-92. PubMed ID: 12515748
[TBL] [Abstract][Full Text] [Related]
16. Kidney function and cerebral small vessel disease in the general population.
Akoudad S; Sedaghat S; Hofman A; Koudstaal PJ; van der Lugt A; Ikram MA; Vernooij MW
Int J Stroke; 2015 Jun; 10(4):603-8. PubMed ID: 25753173
[TBL] [Abstract][Full Text] [Related]
17. Arterial wave reflections and kidney function decline among persons with preserved estimated glomerular filtration rate: the Multi-Ethnic Study of Atherosclerosis.
Hsu JJ; Katz R; Chirinos JA; Jacobs DR; Duprez DA; Peralta CA
J Am Soc Hypertens; 2016 May; 10(5):438-46. PubMed ID: 27085205
[TBL] [Abstract][Full Text] [Related]
18. Role of soluble endothelial cell-selective adhesion molecule biomarker in albuminuria and kidney function changes in patients with coronary artery disease: the Heart and Soul Study.
Park M; Vittinghoff E; Ganz P; Peralta CA; Whooley M; Shlipak MG
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):231-6. PubMed ID: 24177327
[TBL] [Abstract][Full Text] [Related]
19. Nonesterified Fatty Acids and Kidney Function Decline in Older Adults: Findings From the Cardiovascular Health Study.
Walther CP; Ix JH; Biggs ML; Kizer JR; Navaneethan SD; Djoussé L; Mukamal KJ
Am J Kidney Dis; 2021 Aug; 78(2):259-267. PubMed ID: 33548344
[TBL] [Abstract][Full Text] [Related]
20. The association of adiposity with kidney function decline among HIV-infected adults: findings from the Fat Redistribution and Metabolic Changes in HIV Infection (FRAM) study.
Malkina A; Scherzer R; Shlipak MG; Bacchetti P; Tien PC; Grunfeld C; Kosmiski L; Peralta CA
HIV Med; 2015 Mar; 16(3):184-90. PubMed ID: 25251910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
